10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended December 31, 2015

OR

oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from      to      

Commission File Number 1-6549

American Science and Engineering, Inc.

(Exact name of Registrant as specified in its charter)

Massachusetts	04-2240991
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
829 Middlesex Turnpike
Billerica, Massachusetts	01821
(Address of principal executive offices)	(Zip Code)

(978) 262-8700

(Registrant’s telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes x  No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes  x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer o		Accelerated filer	x
Non-accelerated filer   o	(Do not check if a smaller reporting company)	Smaller reporting company	o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Securities Exchange Act of 1934).  Yes o  No x

The number of shares of the registrant’s common stock, $0.66 2/3 par value, outstanding as of February 4, 2016 was 7,170,314.

TABLE OF CONTENTS

Part I — Financial Information
Item 1 — Financial Statements	3
Unaudited Condensed Consolidated Balance Sheets — December 31, 2015 and March 31, 2015	3
Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)— For the three and nine months ended December 31, 2015 and December 31, 2014	4
Unaudited Condensed Consolidated Statements of Cash Flows — For the nine months ended December 31, 2015 and December 31, 2014	5
Notes to Unaudited Condensed Consolidated Financial Statements	6
Item 2 — Management’s Discussion and Analysis of Financial Condition and Results of Operations	12
Item 3 — Quantitative and Qualitative Disclosure About Market Risk	15
Item 4 — Controls and Procedures	16
Part II — Other Information
Item 1A — Risk Factors	16
Item 2 — Unregistered Sales of Equity Securities and Use of Proceeds	16
Item 6 —Exhibits	16
Signatures	17

2

PART I — FINANCIAL INFORMATION

ITEM 1 — FINANCIAL STATEMENTS

AMERICAN SCIENCE AND ENGINEERING, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(In thousands, except share and per share amounts)	December 31,  2015			March 31, 2015
Assets
Current assets:
Cash and cash equivalents	$	87,151		$	68,835
Restricted cash	5,602			6,193
Short-term investments, at fair value	3,000			24,533
Accounts receivable, net of allowances of $283 and $333 at December 31, 2015 and March 31, 2015, respectively	13,723			22,124
Unbilled costs and fees	2,697			1,848
Inventories, net	39,561			40,983
Prepaid expenses and other current assets	9,580			10,701
Deferred income taxes	2,486			2,486
Total current assets	163,800			177,703
Equipment and leasehold improvements, net	6,425			8,711
Restricted cash	1,587			208
Deferred income taxes	5,952			5,952
Other assets	293			534
Total assets	$	178,057		$	193,108
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable	$	5,231		$	7,200
Accrued salaries and benefits	5,203			6,769
Accrued warranty costs	221			159
Deferred revenue	11,158			7,355
Customer deposits	12,076			13,956
Other current liabilities	2,985			5,736
Total current liabilities	36,874			41,175
Deferred revenue	1,861			1,019
Other long-term liabilities	676			507
Total liabilities	39,411			42,701
Stockholders’ equity:
Preferred stock, no par value, 100,000 shares authorized; no shares issued	—			—
Common stock, $0.66 2/3 par value, 20,000,000 shares authorized; 7,167,424 and 7,193,247 shares issued and outstanding at December 31, 2015 and March 31, 2015, respectively	4,778			4,795
Capital in excess of par value	2,930			3,334
Accumulated other comprehensive loss, net	(7		)	(11		)
Retained earnings	130,945			142,289
Total stockholders’ equity	138,646			150,407
Total liabilities and stockholders’ equity	$	178,057		$	193,108

The accompanying notes are an integral part of these condensed consolidated financial statements.

3

AMERICAN SCIENCE AND ENGINEERING, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

(Unaudited)

	Three Months Ended						Nine Months Ended
(In thousands, except per share amounts)	December 31, 2015			December 31, 2014			December 31, 2015			December 31, 2014
Net sales and contract revenues:
Net product sales and contract revenues	$	9,730		$	24,822		$	42,296		$	59,077
Net service revenues	12,443			12,158			36,458			36,506
Total net sales and contract revenues	22,173			36,980			78,754			95,583
Cost of sales and contracts:
Cost of product sales and contracts	5,104			14,040			22,769			32,869
Cost of service revenues	6,173			5,833			18,309			19,455
Total cost of sales and contracts	11,277			19,873			41,078			52,324
Gross profit	10,896			17,107			37,676			43,259
Expenses:
Selling, general and administrative expenses	7,693			7,627			22,735			24,936
Research and development costs	4,576			5,668			16,216			18,092
Total operating expenses	12,269			13,295			38,951			43,028
Operating income (loss)	(1,373		)	3,812			(1,275		)	231
Other income (expense):
Interest and investment income	30			54			119			219
Interest expense	—			(4		)	—			(23		)
Other expense, net	(52		)	(32		)	(317		)	(284		)
Total other expense	(22		)	18			(198		)	(88		)
Income (loss) before provision for (benefit from) income taxes	(1,395		)	3,830			(1,473		)	143
Provision for (benefit from) income taxes	(931		)	1,276			(958		)	41
Net income (loss)	$	(464	)	$	2,554		$	(515	)	$	102
Other comprehensive income (loss):
Unrealized gain (loss) on available for sale securities (net of tax)	—			(16		)	4			(45		)
Comprehensive income (loss)	$	(464	)	$	2,538		$	(511	)	$	57
Income (loss) per share - Basic	$	(0.06	)	$	0.32		$	(0.07	)	$	0.01
Income (loss) per share - Diluted	$	(0.06	)	$	0.32		$	(0.07	)	$	0.01
Weighted average shares — Basic	7,164			7,789			7,158			7,866
Weighted average shares — Diluted	7,164			7,796			7,158			7,877
Dividends declared per share	$	0.50		$	0.50		$	1.50		$	1.50

The accompanying notes are an integral part of these condensed consolidated financial statements.

4

AMERICAN SCIENCE AND ENGINEERING, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	For the Nine Months Ended
(In thousands)	December 31, 2015			December 31, 2014
Cash flows from operating activities:
Net income (loss)	$	(515	)	$	102
Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:
Depreciation and amortization	2,882			3,624
Provisions for contracts, inventory and accounts receivable reserves	(5		)	(237		)
Amortization of bond premium	72			713
Deferred income taxes	—			1,993
Stock compensation expense	1,849			2,266
Other	202			—
Changes in assets and liabilities:
Accounts receivable	8,443			7,500
Unbilled costs and fees	(849		)	(874		)
Inventories	1,385			(9,138		)
Prepaid expenses and other assets	1,362			(6,324		)
Accounts payable	(1,969		)	(3,868		)
Accrued income taxes	—			(2,338		)
Customer deposits	(1,880		)	2,312
Deferred revenue	4,645			(1,781		)
Accrued expenses and other liabilities	(4,086		)	(7,917		)
Net cash provided by (used for) operating activities	11,536			(13,967		)
Cash flows from investing activities:
Purchases of short-term investments	—			(29,211		)
Proceeds from sales and maturities of short-term investments	21,465			56,433
Purchases of property and equipment, net	(798		)	(1,668		)
Net cash provided by investing activities	20,667			25,554
Cash flows from financing activities:
(Increase) decrease in restricted cash	(788		)	2,482
Proceeds from exercise of stock options	—			888
Repurchase of shares of common stock	(2,263		)	(18,799		)
Repayment of leasehold financing liability	—			(928		)
Payment of common stock dividend	(10,836		)	(11,948		)
Increase in income taxes due to the tax impact of employee stock options	—			306
Net cash used for financing activities	(13,887		)	(27,999		)
Net increase (decrease) in cash and cash equivalents	18,316			(16,412		)
Cash and cash equivalents at beginning of period	68,835			62,143
Cash and cash equivalents at end of period	$	87,151		$	45,731

The accompanying notes are an integral part of these condensed consolidated financial statements.

5

AMERICAN SCIENCE AND ENGINEERING, INC. AND SUBSIDIARIES
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

1.GENERAL

The condensed consolidated financial statements include the accounts of American Science and Engineering, Inc. and its wholly owned subsidiaries (the “Company”). All significant intercompany transactions and balances have been eliminated.

The unaudited condensed consolidated financial statements have been prepared in accordance with the requirements of Form 10-Q and consequently do not include all disclosures required by Form 10-K. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2015, or fiscal 2015, as filed with the Securities and Exchange Commission on June 5, 2015.

The unaudited condensed consolidated financial statements, in the opinion of management, include all necessary adjustments, consisting solely of normal recurring adjustments, to present fairly the Company’s financial position, results of operations and cash flows.  These results are not necessarily indicative of the results to be expected for the entire year.

Nature of Operations

The Company develops, manufactures, markets, and sells X-ray inspection and other detection products for homeland security, force protection, public safety and other critical defense and security applications.  The Company provides maintenance, warranty, engineering, and training and operator services related to these products.  The Company has one reporting segment, X-ray detection solutions.

Significant Accounting Policies

For systems that are produced in a standard manufacturing operation and have shorter order to delivery cycles, the Company recognizes sales when title passes and when other revenue recognition criteria (such as transfer of risk and customer acceptance) are met.  Revenues on cost reimbursable and custom long-term fixed price contracts are generally recorded as costs are incurred using the percentage of completion method.

The other significant accounting policies followed by the Company and its subsidiaries in preparing its consolidated financial statements are set forth in Note 1 to the consolidated financial statements included in its Form 10-K for the year ended March 31, 2015.  There have been no changes to the Company’s critical accounting policies during the three and nine months December 31, 2015.

Stock Repurchase Program

On May 7, 2013, the Board of Directors announced the approval of its fifth Stock Repurchase Program which authorized the Company to repurchase up to $35 million of shares of its common stock from time to time on the open market or in privately negotiated transactions.  On December 1, 2014, the Board of Directors announced an expansion of this stock repurchase program increasing the program authorization to $50 million of shares of its common stock.

During the nine months ended December 31, 2015, the Company repurchased 54,056 shares of its common stock at an average price of $41.86.  The Company did not repurchase any shares of stock in the three months ended December 31, 2015.  As of December 31, 2015, the remaining balance available under the Stock Repurchase Program was $11,225,000.

Dividends

	Three Months Ended				Nine Months Ended
(In thousands)	December 31, 2015		December 31, 2014		December 31, 2015		December 31, 2014
Dividends declared	$	0.50	$	0.50	$	1.50	$	1.50
Dividends paid	$	0.50	$	0.50	$	1.50	$	1.50

On February 8, 2016, the Company declared a cash dividend of $0.50 per share. The dividend will be paid on March 2, 2016 to all shareholders of record at the close of business on February 18, 2016.  Future dividends will be declared at the discretion of the Board of Directors and will depend upon such factors as the Board of Directors deems relevant.

Concentrations of Credit Risk

Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of cash and cash equivalents, restricted cash, short-term investments and accounts and unbilled receivables.  At times, the Company maintains

6

cash balances in excess of insured limits. The Company maintains its cash and cash equivalents with major financial institutions.  The Company’s credit risk is managed by investing its cash in money market funds, investment grade corporate debentures/bonds, U.S. government agency bonds, commercial paper, U.S. treasury bills and certificates of deposit.

New Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue From Contracts With Customers, which outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. The ASU is based on the principle that an entity should recognize revenue in an amount that reflects the consideration to which an entity expects to be entitled in exchange for the goods or services transferred to its customers. The ASU also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to fulfill a contract. Entities have the option of using either a full retrospective or a modified retrospective approach for the adoption of the new standard. The guidance is effective for annual periods beginning on or after December 15, 2017 (early adoption for annual periods beginning on or after December 15, 2016 is permitted). The Company is currently assessing the impact that this standard will have on its consolidated financial statements.

In January 2015 the FASB issued ASU No. 2015-01, Income Statement—Extraordinary and Unusual Items, which eliminates from U.S. GAAP the concept of extraordinary items.  Entities may apply the amendments prospectively or retrospectively to all prior periods presented in the financial statements. Early adoption is permitted.  ASU No. 2015-01 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015.  The adoption of this standard is not expected to have a material effect on the Company’s consolidated financial statements.

In July 2015, the FASB issued ASU No. 2015-11, Simplifying the Measurement of Inventory, which requires an entity to measure inventory at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Subsequent measurement is unchanged for inventory measured using last-in, first-out (“LIFO”) or the retail inventory method. It is effective for annual reporting periods beginning after December 15, 2016. The amendments should be applied prospectively with earlier application permitted as of the beginning of an interim or annual reporting period. The Company is currently assessing the impact that this standard will have on its consolidated financial statements.

In November 2015, the FASB issued ASU No. 2015-17, “Balance Sheet Classification of Deferred Taxes (Topic 740, which eliminates the current requirement for companies to present deferred tax liabilities and assets as current and non-current in a classified balance sheet. To simplify the presentation of deferred income taxes, ASU 2015-17 requires that deferred tax liabilities and assets be classified as non-current in a classified statement of financial position. ASU 2015-17 is effective for fiscal years beginning after December 15, 2016 (our fiscal year 2018), including interim periods within that reporting period.  Early adoption is permitted as of the beginning of an interim or annual period. We are currently in the process of evaluating the impact of ASU 2015-17 on our financial position and results of operations.

2.   ACCOUNTING FOR STOCK-BASED COMPENSATION

The Company accounts for stock-based awards made to its employees and Board of Directors in accordance with FASB Accounting Standards Codification (“FASB ASC”) 718, Compensation—Stock Compensation, which requires the measurement and recognition of all compensation costs for stock-based awards made to employees and the Board of Directors based upon the grant date fair value over the requisite service period for awards expected to vest.

The Company recognized $805,000 and $496,000 of stock-based compensation costs for the three months ended December 31, 2015 and December 31, 2014, respectively.  The Company recognized $1,849,000 and $2,266,000 of stock-based compensation costs for the nine months ended December 31, 2015 and December 31, 2014, respectively.  The income tax benefit recognized related to the compensation costs for the three months ended December 31, 2015 and December 31, 2014 was approximately $282,000 and $223,000 respectively.  The income tax benefit recognized related to the compensation costs for the nine months ended December 31, 2015 and December 31, 2014 was approximately $648,000 and $816,000, respectively.

The following table summarizes stock-based compensation costs included in the Company’s consolidated statements of operations and comprehensive income (loss):

	Three Months Ended				Nine Months Ended
(In thousands)	December 31, 2015		December 31, 2014		December 31, 2015		December 31, 2014
Cost of sales and contracts	$	176	$	124	$	289	$	647
Selling, general and administrative	629		372		1,560		1,619
Total share-based compensation expense before tax	$	805	$	496	$	1,849	$	2,266

7

Stock Option and Other Compensation Plans

The Company has various stock option and other compensation plans for directors, officers, and employees.  The Company had the following stock plans outstanding as of December 31, 2015: the 2005 Equity and Incentive Plan and the 2014 Equity and Incentive Plan. There are 366,000 shares remaining available for issuance under these plans. Vesting periods are at the discretion of the Board of Directors and typically range from one to three years.  Options under these plans are granted at fair market value and have a term of ten years from the date of grant.

The Company deems the Black-Scholes option pricing model as the most appropriate method for determining the estimated fair value of stock-based awards. The Black-Scholes method of valuation requires several assumptions: (1) the expected term of the stock-based award; (2) the expected future stock volatility over the expected term; (3) a risk-free interest rate; and (4) the expected dividend yield. The expected term represents the expected period of time that the Company believes the options will be outstanding based on historical information. Estimates of expected future stock price volatility are based on the historic volatility of the Company’s common stock and the risk-free interest rate is based on the U.S. Zero-Bond rate.

Stock Options

The following tables summarize stock option activity for the nine months ended December 31, 2015:

	Number of Shares		Weighted Average Exercise Price ($)		Weighted Average Contractual Life (years)	Aggregate Intrinsic Value
Options outstanding at March 31, 2015	191,834		$	66.03	2.88
Grants	—		—
Exercises	—		—			—
Cancellations	(51,901	)	$	59.34
Options outstanding at December 31, 2015	139,933		$	68.51	2.83
Options exercisable at December 31, 2015	139,933

Information related to the stock options outstanding as of December 31, 2015 is as follows:

Range of Exercise Prices	Number of Shares	Weighted- Average Remaining Contractual Life (years)	Weighted- Average Exercise Price ($)		Exercisable Number of Shares	Exercisable Weighted- Average Exercise Price ($)
$  60.66-$69.99	83,752	2.20	$	64.24	83,752	$	64.24
$  70.00-$75.82	56,181	3.77	74.87		56,181	74.87
$  60.66-$75.82	139,933	2.83	$	68.51	139,933	$	68.51

There were no options granted in the three or nine months ended December 31, 2015.

As of December 31, 2015, there was no remaining unrecognized compensation cost related to options granted.

Restricted Stock and Restricted Stock Units

The Company has instituted long-term incentive plans for certain key employees. These plans call for the issuance of restricted stock, restricted stock units, restricted stock options, and/or cash incentives which vest or are paid upon the achievement of certain performance-based goals as well as service time incurred.  Restricted stock and restricted stock units may also be granted to other employees with vesting periods that range from one to three years.  In addition, annually the non-employee directors are granted restricted stock. Restricted stock shares granted to our non-employee directors vest on a pro-rata basis, based on service performed over the non-employee director’s one-year term of service. Certain of the stock and stock unit awards contain rights to receive non-forfeitable dividends. The fair values of the restricted stock and restricted stock unit awards are equal to the fair value

8

of the Company’s common stock on the date of grant.

Non-vested restricted stock and restricted stock unit awards are subject to the risk of forfeiture until the fulfillment of specified conditions. As of December 31, 2015, there was $5,546,000 of total unrecognized compensation costs related to non-vested restricted stock and restricted stock unit awards granted under the Company’s stock plans. These costs are expected to be recognized over a weighted average period of 1.55 years.

The following table summarizes the status of the Company’s non-vested restricted stock and restricted stock unit awards for the nine months ended December 31, 2015:

	Number of Shares		Weighted Average Grant Date Fair Value ($)
Outstanding at March 31, 2015	91,837		$	62.99
Granted	120,439		43.74
Vested	(23,347	)	55.65
Forfeited	(7,838	)	63.65
Outstanding at December 31, 2015	181,091		$	51.11

3.INVENTORIES

Inventories consist of material, labor and manufacturing overhead and are recorded at the lower of cost, using the weighted average cost method, or net realizable value. Excess manufacturing overhead costs attributable to idle facility expenses, freight, handling costs and wasted material (spoilage) attributable to abnormally low production volumes (levels that materially differ from budgeted production plans due primarily to changes in customer demand) are excluded from inventory and recorded as an expense in the period incurred.

The components of inventories at December 31, 2015 and March 31, 2015 were as follows:

(In thousands)	December 31, 2015		March 31, 2015
Raw materials, completed sub-assemblies, and spare parts	$	21,372	$	20,334
Work-in-process	14,788		17,853
Finished goods	3,401		2,796
Total	$	39,561	$	40,983

4.INCOME PER COMMON AND COMMON EQUIVALENT SHARE

Basic earnings per common share is computed by dividing distributed and undistributed earnings to common stockholders by the weighted average number of shares of common stock outstanding during the period.  Share-based payment awards entitling holders to receive non-forfeitable dividends before vesting are considered participating securities and thus are included in the calculation of basic earnings per share under the two-class method.  Diluted earnings per share include the dilutive impact of options, and restricted stock units using the average share price of the Company’s common stock for the period.  For the three months ended December 31, 2015 and December 31, 2014, common stock equivalents of 331,000 and 244,000 shares, respectively, are excluded from diluted earnings per share, as their effect is anti-dilutive. For the nine months ended December 31, 2015 and December 31, 2014, common stock equivalents of 358,000 and 209,000 shares, respectively, are excluded from diluted earnings per share, as their effect is anti-dilutive.

	Three Months Ended						Nine Months Ended
(In thousands except per share amounts)	December 31, 2015			December 31, 2014			December 31, 2015			December 31, 2014
Income (Loss) Per Share — Basic:
Net income (loss)	$	(464	)	$	2,554		$	(515	)	$	102
Less: Distributed and undistributed earnings (loss) to unvested restricted stock units	(1		)	(27		)	(11		)	(4		)
Distributed and undistributed earnings (loss) to common shareholders — basic	(465		)	2,527			(526		)	98
Weighted average number of common shares outstanding — basic	7,164			7,789			7,158			7,866
Net income (loss) per share — basic	$	(0.06	)	$	0.32		$	(0.07	)	$	0.01
Diluted:
Weighted average number of common shares outstanding	7,164			7,789			7,158			7,866
Add dilutive effect of potential common shares	—			7			—			11
Weighted average number of common and potential common shares outstanding — diluted	7,164			7,796			7,158			7,877
Net income (loss) per share — diluted	$	(0.06	)	$	0. 32		$	(0.07	)	$	0.01

9

5.  LETTERS OF CREDIT

In the normal course of business, the Company may provide certain customers and potential customers with performance guarantees, which are generally backed by standby letters of credit. In general, the Company would only be liable for the amount of these guarantees in the event of default in the performance of its obligations, the probability of which management believes is low.  As of December 31, 2015, the Company had outstanding $13,409,000 in standby letters of credit.  These outstanding standby letters of credit are cash-secured at amounts ranging from 52% to 63% of the outstanding letters of credit, resulting in restricted cash balance of $7,189,000 at December 31, 2015, of which $1,587,000 was considered long-term restricted cash and investments due to the expiration date of the underlying letters of credit.

6.   FAIR VALUE MEASUREMENTS

The Company has categorized its financial assets, based on the priority of the inputs to the valuation technique, into a three-level fair value hierarchy as set forth below. If the inputs used to measure a financial instrument fall within different levels of the hierarchy, the categorization of such financial asset is based on the lowest level input that is significant to the fair value measurement of such instrument.

Financial assets are categorized based on the inputs to the valuation techniques as follows:

Level 1 - Financial assets whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the Company has the ability to access at the measurement date (examples include actively exchange-traded equity securities, listed derivatives, and most U.S. government and agency securities).

Level 2 - Financial assets whose values are based on quoted prices in markets where trading occurs infrequently or whose values are based on quoted prices of instruments with similar attributes in active markets.  Level 2 inputs include the following:

•Quoted prices for identical or similar assets or liabilities in non-active markets;

•Inputs other than quoted prices that are observable for substantially the full term of the asset or liability; and

•Inputs that are derived principally from or corroborated by observable market data for substantially the full term of the asset or liability.

Level 3 - Financial assets whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s assumptions about the assumptions a market participant would use in pricing the asset or liability. The Company currently does not have any Level 3 financial assets or liabilities.

The following table presents the financial assets that the Company measures at fair value on a recurring basis, based on the fair value hierarchy as of December 31, 2015 and March 31, 2015:

(In thousands)	December 31, 2015		March 31, 2015
Level 1 — Financial Assets
Money market funds	$	63,485	$	51,784
Treasury bills	—		5,403
Total Level 1 Financial Assets	63,485		57,187
Level 2 — Financial Assets
Corporate debentures/bonds	3,000		13,813
Government agency bonds	—		5,317
Total Level 2 Financial Assets	3,000		19,130
Total cash equivalents and short-term investments	$	66,485	$	76,317

10

Short-term investments are classified as available-for-sale and are recorded at their fair market values using the specific identification method. As of December 31, 2015, all of the Company’s available-for-sale securities had contractual maturities of seven months or less. The Company had no material realized gains or losses on its available-for-sale securities for the three and nine months ended December 31, 2015 and December 31, 2014. The unrealized holding gains or losses on these securities are included as a component of other comprehensive income (loss), as disclosed in the condensed consolidated statements of operations and comprehensive income (loss).

(In thousands)	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
December 31, 2015:
Short-term investments:
Corporate debentures/bonds	$	3,000	$	—	$	—	$	3,000
Total short-term investments	$	3,000	$	—	$	—	$	3,000
Cash equivalents:
Money market funds	$	63,485	$	—	$	—	$	63,485
Total cash equivalents	$	63,485	$	—	$	—	$	63,485

(In thousands)	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
March 31, 2015:
Short-term investments:
Corporate debentures/bonds	$	13,823	$	—	$	(10	)	$	13,813
Government agency bonds	5,315		2		—			5,317
Treasury bills	5,400		3		—			5,403
Total short-term investments	$	24,538	$	5	$	(10	)	$	24,533
Cash equivalents:
Money market funds	$	51,784	$	—	$	—		$	51,784
Total cash equivalents	$	51,784	$	—	$	—		$	51,784

7.     INCOME TAXES

The Company accounts for income taxes in accordance with FASB ASC 740, Income Taxes, and recognizes deferred income taxes based on the expected future tax consequences of differences between the financial statement basis and the tax basis of assets and liabilities, calculated using enacted tax rates in effect for the year in which the differences are expected to be reflected in the tax return. The Company evaluates the need for a valuation allowance against its net deferred tax assets at period end based upon its three year cumulative income and its projections of future income, and records a valuation allowance against any net deferred tax assets if it is more likely than not that they will not be realized.

In December 2015, the Research and Experimentation Credit, as defined by Internal Revenue Code Section 41(the “R&D Tax Credit”), was reinstated retroactively to January 1, 2015.  Due to this retroactive reinstatement, there was a significant impact on the rate, for both the quarter and year to date.

The Company is currently open to audit under the statute of limitations by the Internal Revenue Service for the years ending March 31, 2013 through 2015 and by various state taxing authorities for the years ending March 31, 2012 through 2015.

8.     GUARANTEES

Certain of the Company’s products carry a one-year warranty, the costs of which are accrued for at the time of shipment or delivery.  Accrual rates are based upon historical experience for the trailing twelve months and management’s judgment of future exposure.  Warranty experience for the three and nine months December 31, 2015 and 2014 was as follows:

	Three Months Ended						Nine Months Ended
(In thousands)	December 31, 2015			December 31, 2014			December 31, 2015			December 31, 2014
Warranty accrual - beginning of period	$	200		$	186		$	159		$	404
Accruals for warranties issued during the period	107			99			281			184
Adjustment of preexisting accrual estimates	(62		)	(42		)	(26		)	(202		)
Warranty costs incurred during the period	(24		)	(61		)	(193		)	(204		)
Warranty accrual — end of period	$	221		$	182		$	221		$	182

11

9.     LEASE COMMITMENTS

In March 2005, the Company renewed its lease agreement for its corporate headquarters and manufacturing facilities in Billerica, Massachusetts.  As part of the lease agreement, the Company’s landlord agreed to certain renovations to the Billerica facility including the construction of additional high bay manufacturing space.  The Company was responsible for a portion of the construction costs and was deemed to be the owner of the building during the construction period under FASB ASC 840, Leases.

In October 2014, the Company entered into an amendment of its lease agreement for the Billerica facilities extending the term of the lease through February 28, 2023 with an adjusted rent schedule commencing October 1, 2014. Due to certain provisions of the amended lease agreements which removed certain continuing financing obligations related to the building, it was determined that the lease no longer qualified as a capital lease and as such, the Company removed the capitalized building, associated accumulated depreciation and lease financing liability from its books.  The associated gain of $381,000 resulting from the removal of the building from our books was deferred and is being amortized over the modified lease term of the property.

10.  COMMITMENTS AND CONTINGENCIES

Deferred Revenue

The Company offers extended warranty and service contracts to its customers. These contracts typically cover a period of one to five years, and include advance payments that are recorded as deferred revenue. Revenue is recognized as services are performed over the life of the contract, which represents the period over which these revenues are earned. Costs associated with these extended warranty and service contracts are expensed to cost of sales and contracts as incurred.

Legal Matters

The Company continues to cooperate with the Office of the Inspector General (“OIG”) of the U.S. General Services Administration (“GSA”) with respect to a subpoena issued on April 17, 2015 and a related investigation being conducted in conjunction with the Department of Defense.  The investigation relates to the Company’s discount practices and compliance with the pricing provisions of the Company’s GSA Schedule contract.  AS&E produced responsive materials to the GSA OIG from May 2015 through November 2015.  The Company continues to cooperate fully with the investigation and at this time management is unable to predict the outcome of the investigation or estimate the amount of possible loss or range of loss with any certainty.  It is possible that the investigation could lead to claims or findings of violations of the False Claims Act in connection with the Company’s GSA contracting activity. Violations of the False Claims Act could result in the imposition of damages, including up to treble damages, plus civil penalties in some cases. The Company has incurred, and will continue to incur, legal costs in connection with the investigation, and could incur other costs, damages or penalties, depending on its outcome, which could be material.

11.SUBSEQUENT EVENT

On February 8, 2016, the Company commenced a cost reduction plan to reduce operating expenses.  In connection with this plan, the Company initiated a workforce reduction. The reduction in workforce affected workers across all business areas of the business.  Affected employees are entitled to receive certain severance and other benefits consistent with their position and tenure with the Company.  The majority of the workforce reduction is expected to be completed by March 31, 2016.  In connection with the reduction, the Company expect to record a charge of approximately $1.6 million to $1.8 million in the fourth quarter fiscal 2016.

ITEM 2 — MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This Quarterly Report on Form 10-Q contains forward-looking statements that involve risks and uncertainties. For this purpose, any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of 1934.  Without limiting the foregoing, the words “believes”, “anticipates”, “plans”, “expects”, “intends”, “should” and similar expressions are intended to identify forward-looking statements.  These statements are not guarantees of future performance and involve certain risks, uncertainties, and assumptions that are difficult to predict, and you should not place undue reliance on our forward-looking statements.  The factors referred to under “Item 1A. Risk Factors”, among others, could cause actual results to differ materially from those indicated by forward-looking statements made herein and presented elsewhere by management from time to time.  We expressly disclaim any obligation to update or alter our forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Overview

American Science and Engineering, Inc. develops and manufactures X-ray inspection systems for homeland security, force protection, public safety and other critical defense applications.  We provide maintenance, warranty, engineering, and training related to these products.

Our primary technologies are Z Backscatter technology, which is used to detect explosives, illegal drugs, and other

12

contraband even when concealed in complex backgrounds, and other technologies that expand the detection capability of our products beyond the material discrimination features of the Z Backscatter technology to include the penetration capability of high-energy transmission X-rays for dense cargos and/or other detection techniques.

Net sales and contract revenues for the third quarter of fiscal year ending March 31, 2016, or fiscal 2016, decreased to $22,173,000 compared to revenues of $36,980,000 for the third quarter of fiscal 2015. We reported an operating loss of $1,373,000 for the third quarter of fiscal 2016 compared to operating income of $3,812,000 for the third quarter of fiscal 2015.  Net loss for the third quarter of fiscal 2016 was $464,000 ($0.06 loss per share, on a diluted basis) compared to net income of $2,554,000 ($0.32 income per share, on a diluted basis) for the third quarter of fiscal 2015. These results represent a 40% decrease in revenues, a $5,185,000 decrease in operating income and a $0.38 negative change in earnings (loss) per share when compared to results for the third quarter of fiscal 2015.

Net sales and contract revenues for the first nine months of fiscal year ending March 31, 2016, or fiscal 2016, decreased to $78,754,000 compared to revenues of $95,583,000 for the first nine months of fiscal 2015. We reported an operating loss of $1,275,000 for the first nine months of fiscal 2016 compared to operating income of $231,000 for the first nine months of fiscal 2015.  Net loss for the first nine months of fiscal 2016 was $515,000 ($0.07 loss per share, on a diluted basis) compared to net income of $102,000 ($0.01 income per share, on a diluted basis) for the first nine months of fiscal 2015. These results represent an 18% decrease in revenues, a $1,506,000 decrease in operating income and a $0.08 negative change in earnings (loss) per share when compared to results for the first nine months of fiscal 2015.

The following table presents net sales and contract revenues by product and service categories:

	Three Months Ended				Nine Months Ended
(In thousands)	December 31, 2015		December 31, 2014		December 31, 2015		December 31, 2014
Cargo Inspection Systems	$	2,638	$	8,577	$	12,228	$	21,758
Mobile Cargo Inspection Systems	2,671		10,792		18,989		25,127
Parcel and Personnel Screening Inspection Systems	3,757		3,016		8,580		5,315
Other product sales and contract revenue	664		2,437		2,499		6,877
Total net product sales and contract revenues	9,730		24,822		42,296		59,077
Net service revenues	12,443		12,158		36,458		36,506
Total net sales and contract revenues	$	22,173	$	36,980	$	78,754	$	95,583

Critical Accounting Policies

We believe that several accounting policies are important to understanding our historical and future performance. We refer to these policies as “critical” because these specific areas generally require us to make judgments and estimates about matters that are uncertain at the time we make the estimate, and different estimates—which also would have been reasonable—could have been used, which would have resulted in different financial results.

The critical accounting policies we identified in our most recent Annual Report on Form 10-K for the fiscal year ended March 31, 2015 are policies related to revenue recognition, inventories and related allowances for obsolete and excess inventory, and income taxes. It is important that the discussion of our operating results that follows be read in conjunction with the critical accounting policies disclosed in our Annual Report on Form 10-K, as filed with the Securities and Exchange Commission on June 5, 2015.  There have been no changes to our critical accounting policies during the three and nine month periods ended December 31, 2015.

Results of Operations

Net sales and contract revenues for the third quarter of fiscal 2016 decreased by $14,807,000 to $22,173,000 compared to the net sales and contract revenues of $36,980,000 for the corresponding period in the prior fiscal year.  Product sales and contract revenues decreased by $15,092,000 from the prior year due primarily to a decrease of $8,121,000 in Mobile Cargo Inspection Systems revenues due to a lower number of units delivered as compared to the prior period, a decrease in Cargo Inspection System revenues of $5,939,000 due to continued delays in the fulfillment of orders in backlog due to customer site delays, and a decrease in other product revenues of $1,773,000 due to a decrease in replacement part orders.  These decreases were offset in part by an increase of $741,000 in Parcel and Personnel Inspection Systems revenues due primarily to the fulfillment of two multiunit orders of the MINI Z system which was introduced in June of 2014.  Net service revenues of $12,443,000 increased by

13

$285,000 from the corresponding period of the prior year due primarily to revenue on fixed price service contracts.

Net sales and contract revenues for the nine months of fiscal 2016 decreased by $16,829,000 to $78,754,000 compared to the net sales and contract revenues of $95,583,000 for the corresponding period in the prior fiscal year.  Product sales and contract revenues decreased by $16,781,000 from the prior year due to a decrease in Cargo Inspection Systems revenues of $9,530,000  due to a decrease in the number of systems delivered as compared to the prior year, a decrease in Mobile Cargo Inspection System revenues of $6,138,000 due to a decrease in the volume of shipments of systems offset in part by an increase in the average price per system and a decrease in other product revenues of $4,378,000 as spares orders for equipment in the war zone decreased with the reduction in force as compared to the prior year.  These decreases were offset in part by an increase of $3,265,000 in Parcel and Personnel Inspection Systems attributable to our introduction of the MINI Z system in June of 2014.  Net service revenues for the first nine months of fiscal 2016 were $36,458,000 and were consistent with the same period in the prior year.

Total cost of sales and contract revenues for the third quarter of fiscal 2016 decreased by $8,596,000 to $11,277,000 as compared to the corresponding period a year ago. Cost of product sales and contract revenues decreased by $8,936,000 to $5,104,000 as compared to the corresponding period a year ago.  Cost of product sales and contract revenues represented 53% of revenues versus 57% of revenues for the corresponding period in the prior year.  The increase in product gross margin percentage was due primarily to improved margin on Parcel and Personnel Inspection Systems due to increased volume and improved margin on Cargo Inspection systems as compared to the prior year.  The cost of service revenues for the third quarter of fiscal 2016 increased by $340,000 to $6,173,000 as compared to the corresponding period a year ago.  Cost of service revenues increased to 50% of revenues from 48% of revenues in the corresponding period.  The resultant decrease in service gross margins in the third quarter of fiscal 2016 is attributable primarily to increase in material costs needed for systems under fixed price contracts as compared to the prior year.

Total cost of sales and contract revenues for the first nine months of fiscal 2016 decreased by $11,246,000 to $41,078,000 as compared to the corresponding period a year ago. Cost of product sales and contract revenues decreased by $10,100,000 to $22,769,000 as compared to the corresponding period a year ago.  Cost of product sales and contract revenues represented 54% of revenues versus 56% of revenues for the corresponding period in the prior year. This margin improvement is attributable to the shift in the product mix from the corresponding period with a greater percentage of revenues derived from our Mobile Cargo products which historically earn higher margins than our other product groups and improved margins on Parcel and Personnel Inspection Systems due to increased volume. The cost of service revenues for the first nine months of fiscal 2016 decreased by $1,146,000 to $18,309,000 as compared to the corresponding period a year ago.  Cost of service revenues decreased to 50% of revenues from 53% of revenues in the corresponding period.  The increase in gross margin percentage in the first nine months of fiscal 2016 as compared to the corresponding prior period is due to reduced costs to support systems under fixed price contracts and the refund of $594,000 in certain employment related taxes associated with international service engineers during the period.  In addition, in the prior year, the Company incurred a one-time charge of $546,000 related to the contract default by a subcontractor.

Selling, general and administrative expenses for the third quarter of fiscal 2016 increased by 1% to $7,693,000 as compared to $7,627,000 in corresponding period a year ago.  Selling, general and administrative expenses represented 35% of revenues in the current period compared to 21% for the corresponding period in the prior year. This increase in cost was attributable primarily to increases in incentive compensation expense of $276,000 and marketing related costs of $184,000 offset in part by decreases of $272,000 in payroll and related costs and other administrative expenses.

Selling, general and administrative expenses for the first nine months of fiscal 2016 decreased by $2,201,000 to $22,735,000 as compared to the corresponding period a year ago.  Selling, general and administrative expenses represented 29% of revenues in the current period compared to 26% for the corresponding period in the prior year.  The decrease in selling, general and administrative expenses from the prior year period was primarily the result of a decrease in payroll and payroll related costs of $1,379,000 due to headcount reductions effected over the prior five quarters, a decrease in incentive compensation expense of $1,047,000, and a decrease in travel related expenses of $189,000 as compared to the prior period,  These decreases were offset in part by an increase in legal costs of $645,000 related to the GSA investigation, intellectual property and other contract related matters, and an increase in marketing related expenses of $154,000 as compared to the prior year.

Company funded research and development expenses for the third quarter of fiscal 2016 decreased by $1,092,000 to $4,576,000 as compared to the corresponding period a year ago.  Research and development expenses represented 21% of revenues in the current quarter compared to 15% for the corresponding period in the prior year. Research and development expenses decreased from the prior year primarily due to cost-cutting measures and headcount reductions effected during the past five quarters and the third quarter of fiscal 2015 contained significant costs from one subcontractor for a product under development.

Company funded research and development expenses for the first nine months of fiscal 2016 decreased by $1,876,000 to $16,216,000 as compared to the corresponding period a year ago.  Research and development expenses represented 21% of revenues in the first nine months of fiscal 2016 as compared to 19% for the corresponding period in the prior year. Research and

14

development expenses decreased from the prior year primarily due to cost-cutting measures and headcount reductions effected during the past five quarters and the third quarter of fiscal 2015 contained significant costs from one subcontractor for a product under development.

Other income (expense), net, was $22,000 of expense for the third quarter of fiscal 2016 as compared to $18,000 of income for the corresponding period a year ago.  Other income (expense), net was $198,000 of expense for the first nine months of fiscal 2016 as compared to $88,000 of expense for the corresponding period a year ago.  The increase in other expense was the result of reduced investment income as well as an increase in foreign currency transaction losses as compared to the prior year.

We reported a pre-tax loss of $1,395,000 in the third quarter of fiscal 2016 as compared to pre-tax income of $3,830,000 in the corresponding period due to the factors described above.  We reported a pre-tax loss of $1,473,000 in the first nine months of fiscal 2016 as compared to pre-tax income of $143,000 in the corresponding period due to the factors described above.

In December 2015, the R&D Tax Credit was reinstated retroactively to January 1, 2015.  Due to this reinstatement of the R&D Tax Credit, there was a significant beneficial impact on our effective rate in the quarter.  Our effective tax rates offsetting our net losses was 67.0% for the third quarter of fiscal 2016 and 65% for the first nine months of fiscal 2016 as compared to an effective tax rate of 33% for the third quarter of fiscal 2015 and 29% for the first nine months of fiscal 2015.

Liquidity and Capital Resources

Our primary source of liquidity is our cash flows from operations.  We believe that our operating cash flows and cash and investments on hand are sufficient for the foreseeable future to fund our working capital requirements, capital expenditures, income tax obligations, dividends payable to our shareholders and performance guarantee collateralizations and also to fund stock repurchases as desired.

Summary of Cash Activities

Cash and cash equivalents increased by $18,316,000 to $87,151,000 at December 31, 2015 compared to $68,835,000 at March 31, 2015.  Cash inflows for the period consisted primarily of:

1)net proceeds from sales and maturities of short-term investments of $21,465,000;

2)a decrease of $8,443,000 in accounts receivable due to the collection of year-end receivables;

3)an increase in deferred revenue of $4,645,000 due to advance billings effected on certain contracts during the period

4)a decrease of $1,385,000 in inventories from year end due to shipments made during the period;  and

5)a decrease of $1,362,000 in prepaid expenses and other assets due primarily to the receipt of tax refunds during the period.

Offsetting these inflows were cash outflows including:

1)the payment of $10,836,000 in common stock dividends during the period as part of our quarterly dividend program;

2)the payment of $2,263,000 to repurchase 54,056 shares of our common stock during the period;

3)a decrease in accrued expenses and other liabilities of $4,086,000 due to reductions in payroll and incentive compensation related accruals and reduced contract related liabilities as compared to year end;

4)a decrease of $1,880,000 in customer deposits due to revenues earned during the period; and

5)a decrease in accounts payable of $1,969,000 from the year end.

In the normal course of business, we may provide certain customers and potential customers with performance guarantees, which are generally backed by standby letters of credit. In general, we would only be liable for the amount of these guarantees in the event of default in the performance of our obligations; the probability of which our management believes is low.  As of December 31, 2015, we had outstanding $13,409,000 in standby letters of credit.  These outstanding standby letters of credit are cash-secured at amounts ranging from 52% to 63% of the outstanding letters of credit, resulting in restricted cash balance of $7,189,000 at December 31, 2015, of which $1,587,000 was considered long-term restricted cash due to the expiration date of the underlying letters of credit.

ITEM 3 — QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

There were no material changes in the quantitative and qualitative information about market risk since the end of our most recent fiscal year.  For further information, see Item 7A of our Annual Report on Form 10-K for the fiscal year ended March 31, 2015, as filed with the Securities and Exchange Commission on June 5, 2015.

15

ITEM 4 — CONTROLS AND PROCEDURES

a)    Evaluation of disclosure controls and procedures

As of the end of the period covered by this report, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we reviewed and evaluated the effectiveness of our Company’s disclosure controls and procedures pursuant to Rule 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 as amended (the “Exchange Act”). Based upon their evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed by the Company in the reports filed and submitted by it under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and to provide reasonable assurance that information required to be disclosed by us in such reports is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

b)    Changes in internal control over financial reporting

There have been no changes in our internal control over financial reporting as such term is defined in Rule 13a-15(f) and 15d-15(f) of the Exchange Act during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II — OTHER INFORMATION

ITEM 1A — RISK FACTORS

You should carefully review and consider the information regarding certain factors which could materially affect our business, financial condition or future results set forth under Item 1A. “Risk Factors” in our Form 10-K for the fiscal year ended March 31, 2015 as filed with the Securities and Exchange Commission on June 5, 2015. There have been no material changes from the factors disclosed in our Form 10-K for the year ended March 31, 2015, although we may disclose changes to such factors or disclose additional factors from time to time in our future filings with the Securities and Exchange Commission.

ITEM 2 — UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

On May 7, 2013, the Board of Directors announced the approval of a Stock Repurchase Program which authorizes us to repurchase up to $35.0 million of shares of our common stock from time to time on the open market or in privately negotiated transactions. On December 1, 2014, the Board of Directors announced an expansion of this stock repurchase program increasing the program authorization to $50 million of shares of our common stock.

During the three months ended December 31, 2015, the Company did not repurchase any shares of its common stock.  As of December 31, 2015, the remaining balance available under the Stock Repurchase Program was $11,225,000.

ITEM 6 — EXHIBITS

The exhibits listed on the Exhibit Index immediately following the signature page to this Quarterly Report on Form 10-Q are incorporated herein by reference, and are filed or furnished as part of this Quarterly Report on Form 10-Q.

The information required by Exhibit Item 11 (Statement re: Computation of Income per Common and Common Equivalent Share) may be found in Note 4 to the Unaudited Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q.

16

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

	AMERICAN SCIENCE AND ENGINEERING, INC.
Date: February 8, 2016	/s/ Diane J. Basile
	Diane J. Basile
	Senior Vice President, Chief Financial Officer and Treasurer (Principal Financial Officer)

17

EXHIBIT INDEX

Exhibit Number		Description of Exhibits
10.1	*	Offer letter, dated January 5, 2016, between American Science and Engineering, Inc. and Diane J. Basile (filed as Exhibit 10.1 to the Company’s filing on Form 8-K filed on January 11, 2016 and incorporated herein by reference)
31.1	†	Certification by Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
31.2	†	Certification by Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002*
32.1	†	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
32.2	†	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
101	†	The following financial information from American Science and Engineering Inc.’s Quarterly Report on Form 10-Q for the quarter ended December 31, 2015, formatted in XBRL (eXtensible Business Reporting Language) includes: (i) Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) for the three and nine months ended December 31, 2015 and 2014, (ii) Condensed Consolidated Balance Sheets at December 31, 2015 and March 31, 2015, (iii) Condensed Consolidated Statements of Cash Flows for the nine months ended December 31, 2015 and 2014, and (iv) the Notes to Condensed Consolidated Financial Statements.

* Management contract or compensatory plan or arrangement

†   Filed herewith

18

EX-31.1

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

Section 302 Certification

I, Charles P. Dougherty, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of American Science and Engineering, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 8, 2016	/s/ Charles P. Dougherty
	Charles P. Dougherty President and Chief Executive Officer (Principal Executive Officer)

1

EX-31.2

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

Section 302 Certification

I, Diane J. Basile, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of American Science and Engineering, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 8, 2016	/s/ Diane J. Basile
	Diane J. Basile
	Senior Vice President, Chief Financial Officer and Treasurer (Principal Financial Officer)

1

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, the President and Chief Executive Officer of American Science and Engineering, Inc. (the “Company”), does hereby certify that to the undersigned’s knowledge:

1.the Company’s Quarterly Report on Form 10-Q for the quarter ended December 31, 2015 (the “10-Q”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.the information contained in the 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: February 8, 2016	/s/ Charles P. Dougherty
	Charles P. Dougherty President and Chief Executive Officer (Principal Executive Officer)

A signed original of this written statement required by Section 906 has been provided to American Science and Engineering, Inc. and will be retained by American Science and Engineering, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

1

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, the Senior Vice President, Chief Financial Officer and Treasurer of American Science and Engineering, Inc. (the “Company”), does hereby certify that to the undersigned’s knowledge:

1.the Company’s Quarterly Report on Form 10-Q for the quarter ended December 31, 2015 (the “10-Q”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.the information contained in the 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: February 8, 2016	/s/ Diane J. Basile
	Diane J. Basile
	Senior Vice President, Chief Financial Officer and Treasurer (Principal Financial Officer)

A signed original of this written statement required by Section 906 has been provided to American Science and Engineering, Inc. and will be retained by American Science and Engineering, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

1

XML

Document and Entity Information - shares	9 Months Ended
	Dec. 31, 2015	Feb. 04, 2016
Document and Entity Information
Entity Registrant Name	AMERICAN SCIENCE & ENGINEERING, INC.
Entity Central Index Key	0000005768
Document Type	10-Q
Document Period End Date	Dec. 31, 2015
Amendment Flag	false
Current Fiscal Year End Date	--03-31
Entity Current Reporting Status	Yes
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		7,170,314
Document Fiscal Year Focus	2016
Document Fiscal Period Focus	Q3

XML

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2015	Mar. 31, 2015
Current assets:
Cash and cash equivalents	$ 87,151	$ 68,835
Restricted cash	5,602	6,193
Short-term investments, at fair value	3,000	24,533
Accounts receivable, net of allowances of $283 and $333 at December 31, 2015 and March 31, 2015, respectively	13,723	22,124
Unbilled costs and fees	2,697	1,848
Inventories, net	39,561	40,983
Prepaid expenses and other current assets	9,580	10,701
Deferred income taxes	2,486	2,486
Total current assets	163,800	177,703
Equipment and leasehold improvements, net	6,425	8,711
Restricted cash	1,587	208
Deferred income taxes	5,952	5,952
Other assets	293	534
Total assets	178,057	193,108
Current liabilities:
Accounts payable	5,231	7,200
Accrued salaries and benefits	5,203	6,769
Accrued warranty costs	221	159
Deferred revenue	11,158	7,355
Customer deposits	12,076	13,956
Other current liabilities	2,985	5,736
Total current liabilities	36,874	41,175
Deferred revenue	1,861	1,019
Other long-term liabilities	676	507
Total liabilities	$ 39,411	$ 42,701
Stockholders' equity:
Preferred stock, no par value, 100,000 shares authorized; no shares issued
Common stock, $0.66 2/3 par value, 20,000,000 shares authorized; 7,167,424 and 7,193,247 shares issued and outstanding at December 31, 2015 and March 31, 2015, respectively	$ 4,778	$ 4,795
Capital in excess of par value	2,930	3,334
Accumulated other comprehensive loss, net	(7)	(11)
Retained earnings	130,945	142,289
Total stockholders' equity	138,646	150,407
Total liabilities and stockholders' equity	$ 178,057	$ 193,108

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2015	Mar. 31, 2015
CONDENSED CONSOLIDATED BALANCE SHEETS
Accounts receivable, allowances (in dollars)	$ 283	$ 333
Preferred stock, no par value (in dollars per share)	$ 0	$ 0
Preferred stock, shares authorized	100,000	100,000
Preferred stock, shares issued	0	0
Common stock, par value (in dollars per share)	$ 0.6666	$ 0.6666
Common stock, shares authorized	20,000,000	20,000,000
Common stock, shares issued	7,167,424	7,193,247
Common stock, shares outstanding	7,167,424	7,193,247

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2015	Dec. 31, 2014
Net sales and contract revenues:
Net product sales and contract revenues	$ 9,730	$ 24,822	$ 42,296	$ 59,077
Net service revenues	12,443	12,158	36,458	36,506
Total net sales and contract revenues	22,173	36,980	78,754	95,583
Cost of sales and contracts:
Cost of product sales and contracts	5,104	14,040	22,769	32,869
Cost of service revenues	6,173	5,833	18,309	19,455
Total cost of sales and contracts	11,277	19,873	41,078	52,324
Gross profit	10,896	17,107	37,676	43,259
Expenses:
Selling, general and administrative expenses	7,693	7,627	22,735	24,936
Research and development costs	4,576	5,668	16,216	18,092
Total operating expenses	12,269	13,295	38,951	43,028
Operating income (loss)	(1,373)	3,812	(1,275)	231
Other income (expense):
Interest and investment income	30	54	119	219
Interest expense		(4)		(23)
Other expense, net	(52)	(32)	(317)	(284)
Total other expense	(22)	18	(198)	(88)
Income (loss) before provision for (benefit from) income taxes	(1,395)	3,830	(1,473)	143
Provision for (benefit from) income taxes	(931)	1,276	(958)	41
Net income (loss)	(464)	2,554	(515)	102
Other comprehensive income (loss):
Unrealized gain (loss) on available for sale securities (net of tax)		(16)	4	(45)
Comprehensive income (loss)	$ (464)	$ 2,538	$ (511)	$ 57
Income (loss) per share - Basic (in dollars per share)	$ (0.06)	$ 0.32	$ (0.07)	$ 0.01
Income (loss) per share - Diluted (in dollars per share)	$ (0.06)	$ 0.32	$ (0.07)	$ 0.01
Weighted average shares - Basic (in shares)	7,164	7,789	7,158	7,866
Weighted average shares - Diluted (in shares)	7,164	7,796	7,158	7,877
Dividends declared per share (in dollars per share)	$ 0.50	$ 0.50	$ 1.50	$ 1.50

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Cash flows from operating activities:
Net income (loss)	$ (515)	$ 102
Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:
Depreciation and amortization	2,882	3,624
Provisions for contracts, inventory and accounts receivable reserves	(5)	(237)
Amortization of bond premium	72	713
Deferred income taxes		1,993
Stock compensation expense	1,849	2,266
Other	202
Changes in assets and liabilities:
Accounts receivable	8,443	7,500
Unbilled costs and fees	(849)	(874)
Inventories	1,385	(9,138)
Prepaid expenses and other assets	1,362	(6,324)
Accounts payable	(1,969)	(3,868)
Accrued income taxes		(2,338)
Customer deposits	(1,880)	2,312
Deferred revenue	4,645	(1,781)
Accrued expenses and other liabilities	(4,086)	(7,917)
Net cash provided by (used for) operating activities	11,536	(13,967)
Cash flows from investing activities:
Purchases of short-term investments		(29,211)
Proceeds from sales and maturities of short-term investments	21,465	56,433
Purchases of property and equipment, net	(798)	(1,668)
Net cash provided by investing activities	20,667	25,554
Cash flows from financing activities:
(Increase) decrease in restricted cash	(788)	2,482
Proceeds from exercise of stock options		888
Repurchase of shares of common stock	(2,263)	(18,799)
Repayment of leasehold financing liability		(928)
Payment of common stock dividend	(10,836)	(11,948)
Increase in income taxes due to the tax impact of employee stock options		306
Net cash used for financing activities	(13,887)	(27,999)
Net increase (decrease) in cash and cash equivalents	18,316	(16,412)
Cash and cash equivalents at beginning of period	68,835	62,143
Cash and cash equivalents at end of period	$ 87,151	$ 45,731

XML

GENERAL

9 Months Ended

Dec. 31, 2015

GENERAL

GENERAL

1.GENERAL

The condensed consolidated financial statements include the accounts of American Science and Engineering, Inc. and its wholly owned subsidiaries (the “Company”). All significant intercompany transactions and balances have been eliminated.

The unaudited condensed consolidated financial statements have been prepared in accordance with the requirements of Form 10-Q and consequently do not include all disclosures required by Form 10-K. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2015, or fiscal 2015, as filed with the Securities and Exchange Commission on June 5, 2015.

The unaudited condensed consolidated financial statements, in the opinion of management, include all necessary adjustments, consisting solely of normal recurring adjustments, to present fairly the Company’s financial position, results of operations and cash flows.  These results are not necessarily indicative of the results to be expected for the entire year.

Nature of Operations

The Company develops, manufactures, markets, and sells X-ray inspection and other detection products for homeland security, force protection, public safety and other critical defense and security applications.  The Company provides maintenance, warranty, engineering, and training and operator services related to these products.  The Company has one reporting segment, X-ray detection solutions.

Significant Accounting Policies

For systems that are produced in a standard manufacturing operation and have shorter order to delivery cycles, the Company recognizes sales when title passes and when other revenue recognition criteria (such as transfer of risk and customer acceptance) are met.  Revenues on cost reimbursable and custom long-term fixed price contracts are generally recorded as costs are incurred using the percentage of completion method.

The other significant accounting policies followed by the Company and its subsidiaries in preparing its consolidated financial statements are set forth in Note 1 to the consolidated financial statements included in its Form 10-K for the year ended March 31, 2015.  There have been no changes to the Company’s critical accounting policies during the three and nine months December 31, 2015.

Stock Repurchase Program

On May 7, 2013, the Board of Directors announced the approval of its fifth Stock Repurchase Program which authorized the Company to repurchase up to $35 million of shares of its common stock from time to time on the open market or in privately negotiated transactions.  On December 1, 2014, the Board of Directors announced an expansion of this stock repurchase program increasing the program authorization to $50 million of shares of its common stock.

During the nine months ended December 31, 2015, the Company repurchased 54,056 shares of its common stock at an average price of $41.86.  The Company did not repurchase any shares of stock in the three months ended December 31, 2015.  As of December 31, 2015, the remaining balance available under the Stock Repurchase Program was $11,225,000.

Dividends

	Three Months Ended				Nine Months Ended
(In thousands)	December 31, 2015		December 31, 2014		December 31, 2015		December 31, 2014
Dividends declared	$	0.50	$	0.50	$	1.50	$	1.50
Dividends paid	$	0.50	$	0.50	$	1.50	$	1.50

On February 8, 2016, the Company declared a cash dividend of $0.50 per share. The dividend will be paid on March 2, 2016 to all shareholders of record at the close of business on February 18, 2016.  Future dividends will be declared at the discretion of the Board of Directors and will depend upon such factors as the Board of Directors deems relevant.

Concentrations of Credit Risk

Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of cash and cash equivalents, restricted cash, short-term investments and accounts and unbilled receivables.  At times, the Company maintains cash balances in excess of insured limits. The Company maintains its cash and cash equivalents with major financial institutions.  The Company’s credit risk is managed by investing its cash in money market funds, investment grade corporate debentures/bonds, U.S. government agency bonds, commercial paper, U.S. treasury bills and certificates of deposit.

New Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue From Contracts With Customers, which outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. The ASU is based on the principle that an entity should recognize revenue in an amount that reflects the consideration to which an entity expects to be entitled in exchange for the goods or services transferred to its customers. The ASU also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to fulfill a contract. Entities have the option of using either a full retrospective or a modified retrospective approach for the adoption of the new standard. The guidance is effective for annual periods beginning on or after December 15, 2017 (early adoption for annual periods beginning on or after December 15, 2016 is permitted). The Company is currently assessing the impact that this standard will have on its consolidated financial statements.

In January 2015 the FASB issued ASU No. 2015-01, Income Statement—Extraordinary and Unusual Items, which eliminates from U.S. GAAP the concept of extraordinary items.  Entities may apply the amendments prospectively or retrospectively to all prior periods presented in the financial statements. Early adoption is permitted.  ASU No. 2015-01 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015.  The adoption of this standard is not expected to have a material effect on the Company’s consolidated financial statements.

In July 2015, the FASB issued ASU No. 2015-11, Simplifying the Measurement of Inventory, which requires an entity to measure inventory at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Subsequent measurement is unchanged for inventory measured using last-in, first-out (“LIFO”) or the retail inventory method. It is effective for annual reporting periods beginning after December 15, 2016. The amendments should be applied prospectively with earlier application permitted as of the beginning of an interim or annual reporting period. The Company is currently assessing the impact that this standard will have on its consolidated financial statements.

In November 2015, the FASB issued ASU No. 2015-17, “Balance Sheet Classification of Deferred Taxes (Topic 740, which eliminates the current requirement for companies to present deferred tax liabilities and assets as current and non-current in a classified balance sheet. To simplify the presentation of deferred income taxes, ASU 2015-17 requires that deferred tax liabilities and assets be classified as non-current in a classified statement of financial position. ASU 2015-17 is effective for fiscal years beginning after December 15, 2016 (our fiscal year 2018), including interim periods within that reporting period.  Early adoption is permitted as of the beginning of an interim or annual period. We are currently in the process of evaluating the impact of ASU 2015-17 on our financial position and results of operations.

XML

ACCOUNTING FOR STOCK-BASED COMPENSATION

9 Months Ended

Dec. 31, 2015

ACCOUNTING FOR STOCK-BASED COMPENSATION

ACCOUNTING FOR STOCK-BASED COMPENSATION

2.ACCOUNTING FOR STOCK-BASED COMPENSATION

The Company accounts for stock-based awards made to its employees and Board of Directors in accordance with FASB Accounting Standards Codification (“FASB ASC”) 718, Compensation—Stock Compensation, which requires the measurement and recognition of all compensation costs for stock-based awards made to employees and the Board of Directors based upon the grant date fair value over the requisite service period for awards expected to vest.

The Company recognized $805,000 and $496,000 of stock-based compensation costs for the three months ended December 31, 2015 and December 31, 2014, respectively.  The Company recognized $1,849,000 and $2,266,000 of stock-based compensation costs for the nine months ended December 31, 2015 and December 31, 2014, respectively.  The income tax benefit recognized related to the compensation costs for the three months ended December 31, 2015 and December 31, 2014 was approximately $282,000 and $223,000 respectively.  The income tax benefit recognized related to the compensation costs for the nine months ended December 31, 2015 and December 31, 2014 was approximately $648,000 and $816,000, respectively.

The following table summarizes stock-based compensation costs included in the Company’s consolidated statements of operations and comprehensive income (loss):

	Three Months Ended				Nine Months Ended
(In thousands)	December 31, 2015		December 31, 2014		December 31, 2015		December 31, 2014
Cost of sales and contracts	$	176	$	124	$	289	$	647
Selling, general and administrative	629		372		1,560		1,619
Total share-based compensation expense before tax	$	805	$	496	$	1,849	$	2,266

Stock Option and Other Compensation Plans

The Company has various stock option and other compensation plans for directors, officers, and employees.  The Company had the following stock plans outstanding as of December 31, 2015: the 2005 Equity and Incentive Plan and the 2014 Equity and Incentive Plan. There are 366,000 shares remaining available for issuance under these plans. Vesting periods are at the discretion of the Board of Directors and typically range from one to three years.  Options under these plans are granted at fair market value and have a term of ten years from the date of grant.

The Company deems the Black-Scholes option pricing model as the most appropriate method for determining the estimated fair value of stock-based awards. The Black-Scholes method of valuation requires several assumptions: (1) the expected term of the stock-based award; (2) the expected future stock volatility over the expected term; (3) a risk-free interest rate; and (4) the expected dividend yield. The expected term represents the expected period of time that the Company believes the options will be outstanding based on historical information. Estimates of expected future stock price volatility are based on the historic volatility of the Company’s common stock and the risk-free interest rate is based on the U.S. Zero-Bond rate.

Stock Options

The following tables summarize stock option activity for the nine months ended December 31, 2015:

	Number of Shares		Weighted Average Exercise Price ($)		Weighted Average Contractual Life (years)	Aggregate Intrinsic Value
Options outstanding at March 31, 2015	191,834		$	66.03	2.88
Grants	—		—
Exercises	—		—			—
Cancellations	(51,901	)	$	59.34
Options outstanding at December 31, 2015	139,933		$	68.51	2.83
Options exercisable at December 31, 2015	139,933

Information related to the stock options outstanding as of December 31, 2015 is as follows:

Range of Exercise Prices	Number of Shares	Weighted- Average Remaining Contractual Life (years)	Weighted- Average Exercise Price ($)		Exercisable Number of Shares	Exercisable Weighted- Average Exercise Price ($)
$  60.66-$69.99	83,752	2.20	$	64.24	83,752	$	64.24
$  70.00-$75.82	56,181	3.77	74.87		56,181	74.87
$  60.66-$75.82	139,933	2.83	$	68.51	139,933	$	68.51

There were no options granted in the three or nine months ended December 31, 2015.

As of December 31, 2015, there was no remaining unrecognized compensation cost related to options granted.

Restricted Stock and Restricted Stock Units

The Company has instituted long-term incentive plans for certain key employees. These plans call for the issuance of restricted stock, restricted stock units, restricted stock options, and/or cash incentives which vest or are paid upon the achievement of certain performance-based goals as well as service time incurred.  Restricted stock and restricted stock units may also be granted to other employees with vesting periods that range from one to three years.  In addition, annually the non-employee directors are granted restricted stock. Restricted stock shares granted to our non-employee directors vest on a pro-rata basis, based on service performed over the non-employee director’s one-year term of service. Certain of the stock and stock unit awards contain rights to receive non-forfeitable dividends. The fair values of the restricted stock and restricted stock unit awards are equal to the fair value of the Company’s common stock on the date of grant.

Non-vested restricted stock and restricted stock unit awards are subject to the risk of forfeiture until the fulfillment of specified conditions. As of December 31, 2015, there was $5,546,000 of total unrecognized compensation costs related to non-vested restricted stock and restricted stock unit awards granted under the Company’s stock plans. These costs are expected to be recognized over a weighted average period of 1.55 years.

The following table summarizes the status of the Company’s non-vested restricted stock and restricted stock unit awards for the nine months ended December 31, 2015:

	Number of Shares		Weighted Average Grant Date Fair Value ($)
Outstanding at March 31, 2015	91,837		$	62.99
Granted	120,439		43.74
Vested	(23,347	)	55.65
Forfeited	(7,838	)	63.65
Outstanding at December 31, 2015	181,091		$	51.11

XML

INVENTORIES

9 Months Ended

Dec. 31, 2015

INVENTORIES

INVENTORIES

3.INVENTORIES

Inventories consist of material, labor and manufacturing overhead and are recorded at the lower of cost, using the weighted average cost method, or net realizable value. Excess manufacturing overhead costs attributable to idle facility expenses, freight, handling costs and wasted material (spoilage) attributable to abnormally low production volumes (levels that materially differ from budgeted production plans due primarily to changes in customer demand) are excluded from inventory and recorded as an expense in the period incurred.

The components of inventories at December 31, 2015 and March 31, 2015 were as follows:

(In thousands)	December 31, 2015		March 31, 2015
Raw materials, completed sub-assemblies, and spare parts	$	21,372	$	20,334
Work-in-process	14,788		17,853
Finished goods	3,401		2,796
Total	$	39,561	$	40,983

XML

INCOME PER COMMON AND COMMON EQUIVALENT SHARE

9 Months Ended

Dec. 31, 2015

INCOME PER COMMON AND COMMON EQUIVALENT SHARE

INCOME PER COMMON AND COMMON EQUIVALENT SHARE

4.INCOME PER COMMON AND COMMON EQUIVALENT SHARE

Basic earnings per common share is computed by dividing distributed and undistributed earnings to common stockholders by the weighted average number of shares of common stock outstanding during the period.  Share-based payment awards entitling holders to receive non-forfeitable dividends before vesting are considered participating securities and thus are included in the calculation of basic earnings per share under the two-class method.  Diluted earnings per share include the dilutive impact of options, and restricted stock units using the average share price of the Company’s common stock for the period.  For the three months ended December 31, 2015 and December 31, 2014, common stock equivalents of 331,000 and 244,000 shares, respectively, are excluded from diluted earnings per share, as their effect is anti-dilutive. For the nine months ended December 31, 2015 and December 31, 2014, common stock equivalents of 358,000 and 209,000 shares, respectively, are excluded from diluted earnings per share, as their effect is anti-dilutive.

	Three Months Ended						Nine Months Ended
(In thousands except per share amounts)	December 31, 2015			December 31, 2014			December 31, 2015			December 31, 2014
Income (Loss) Per Share — Basic:
Net income (loss)	$	(464	)	$	2,554		$	(515	)	$	102
Less: Distributed and undistributed earnings (loss) to unvested restricted stock units	(1		)	(27		)	(11		)	(4		)
Distributed and undistributed earnings (loss) to common shareholders — basic	(465		)	2,527			(526		)	98
Weighted average number of common shares outstanding — basic	7,164			7,789			7,158			7,866
Net income (loss) per share — basic	$	(0.06	)	$	0.32		$	(0.07	)	$	0.01
Diluted:
Weighted average number of common shares outstanding	7,164			7,789			7,158			7,866
Add dilutive effect of potential common shares	—			7			—			11
Weighted average number of common and potential common shares outstanding — diluted	7,164			7,796			7,158			7,877
Net income (loss) per share — diluted	$	(0.06	)	$	0.32		$	(0.07	)	$	0.01

XML

LETTERS OF CREDIT

9 Months Ended

Dec. 31, 2015

LETTERS OF CREDIT

LETTERS OF CREDIT

5.LETTERS OF CREDIT

In the normal course of business, the Company may provide certain customers and potential customers with performance guarantees, which are generally backed by standby letters of credit. In general, the Company would only be liable for the amount of these guarantees in the event of default in the performance of its obligations, the probability of which management believes is low.  As of December 31, 2015, the Company had outstanding $13,409,000 in standby letters of credit.  These outstanding standby letters of credit are cash-secured at amounts ranging from 52% to 63% of the outstanding letters of credit, resulting in restricted cash balance of $7,189,000 at December 31, 2015, of which $1,587,000 was considered long-term restricted cash and investments due to the expiration date of the underlying letters of credit.

XML

FAIR VALUE MEASUREMENTS

9 Months Ended

Dec. 31, 2015

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS

6.FAIR VALUE MEASUREMENTS

The Company has categorized its financial assets, based on the priority of the inputs to the valuation technique, into a three-level fair value hierarchy as set forth below. If the inputs used to measure a financial instrument fall within different levels of the hierarchy, the categorization of such financial asset is based on the lowest level input that is significant to the fair value measurement of such instrument.

Financial assets are categorized based on the inputs to the valuation techniques as follows:

Level 1 - Financial assets whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the Company has the ability to access at the measurement date (examples include actively exchange-traded equity securities, listed derivatives, and most U.S. government and agency securities).

Level 2 - Financial assets whose values are based on quoted prices in markets where trading occurs infrequently or whose values are based on quoted prices of instruments with similar attributes in active markets.  Level 2 inputs include the following:

· Quoted prices for identical or similar assets or liabilities in non-active markets;

· Inputs other than quoted prices that are observable for substantially the full term of the asset or liability; and

· Inputs that are derived principally from or corroborated by observable market data for substantially the full term of the asset or liability.

Level 3 - Financial assets whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s assumptions about the assumptions a market participant would use in pricing the asset or liability. The Company currently does not have any Level 3 financial assets or liabilities.

The following table presents the financial assets that the Company measures at fair value on a recurring basis, based on the fair value hierarchy as of December 31, 2015 and March 31, 2015:

(In thousands)	December 31, 2015		March 31, 2015
Level 1 — Financial Assets
Money market funds	$	63,485	$	51,784
Treasury bills	—		5,403
Total Level 1 Financial Assets	63,485		57,187
Level 2 — Financial Assets
Corporate debentures/bonds	3,000		13,813
Government agency bonds	—		5,317
Total Level 2 Financial Assets	3,000		19,130
Total cash equivalents and short-term investments	$	66,485	$	76,317

Short-term investments are classified as available-for-sale and are recorded at their fair market values using the specific identification method. As of December 31, 2015, all of the Company’s available-for-sale securities had contractual maturities of seven months or less. The Company had no material realized gains or losses on its available-for-sale securities for the three and nine months ended December 31, 2015 and December 31, 2014. The unrealized holding gains or losses on these securities are included as a component of other comprehensive income (loss), as disclosed in the condensed consolidated statements of operations and comprehensive income (loss).

(In thousands)	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
December 31, 2015:
Short-term investments:
Corporate debentures/bonds	$	3,000	$	—	$	—	$	3,000
Total short-term investments	$	3,000	$	—	$	—	$	3,000
Cash equivalents:
Money market funds	$	63,485	$	—	$	—	$	63,485
Total cash equivalents	$	63,485	$	—	$	—	$	63,485

(In thousands)	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
March 31, 2015:
Short-term investments:
Corporate debentures/bonds	$	13,823	$	—	$	(10	)	$	13,813
Government agency bonds	5,315		2		—			5,317
Treasury bills	5,400		3		—			5,403
Total short-term investments	$	24,538	$	5	$	(10	)	$	24,533
Cash equivalents:
Money market funds	$	51,784	$	—	$	—		$	51,784
Total cash equivalents	$	51,784	$	—	$	—		$	51,784

XML

INCOME TAXES

9 Months Ended

Dec. 31, 2015

INCOME TAXES

INCOME TAXES

7.INCOME TAXES

The Company accounts for income taxes in accordance with FASB ASC 740, Income Taxes, and recognizes deferred income taxes based on the expected future tax consequences of differences between the financial statement basis and the tax basis of assets and liabilities, calculated using enacted tax rates in effect for the year in which the differences are expected to be reflected in the tax return. The Company evaluates the need for a valuation allowance against its net deferred tax assets at period end based upon its three year cumulative income and its projections of future income, and records a valuation allowance against any net deferred tax assets if it is more likely than not that they will not be realized.

In December 2015, the Research and Experimentation Credit, as defined by Internal Revenue Code Section 41(the “R&D Tax Credit”), was reinstated retroactively to January 1, 2015.  Due to this retroactive reinstatement, there was a significant impact on the rate, for both the quarter and year to date.

The Company is currently open to audit under the statute of limitations by the Internal Revenue Service for the years ending March 31, 2013 through 2015 and by various state taxing authorities for the years ending March 31, 2012 through 2015.

XML

GUARANTEES

9 Months Ended

Dec. 31, 2015

GUARANTEES

GUARANTEES

8.GUARANTEES

Certain of the Company’s products carry a one-year warranty, the costs of which are accrued for at the time of shipment or delivery.  Accrual rates are based upon historical experience for the trailing twelve months and management’s judgment of future exposure.  Warranty experience for the three and nine months December 31, 2015 and 2014 was as follows:

	Three Months Ended						Nine Months Ended
(In thousands)	December 31, 2015			December 31, 2014			December 31, 2015			December 31, 2014
Warranty accrual - beginning of period	$	200		$	186		$	159		$	404
Accruals for warranties issued during the period	107			99			281			184
Adjustment of preexisting accrual estimates	(62		)	(42		)	(26		)	(202		)
Warranty costs incurred during the period	(24		)	(61		)	(193		)	(204		)
Warranty accrual — end of period	$	221		$	182		$	221		$	182

XML

LEASE COMMITMENTS

9 Months Ended

Dec. 31, 2015

LEASE COMMITMENTS

LEASE COMMITMENTS

9.LEASE COMMITMENTS

In March 2005, the Company renewed its lease agreement for its corporate headquarters and manufacturing facilities in Billerica, Massachusetts.  As part of the lease agreement, the Company’s landlord agreed to certain renovations to the Billerica facility including the construction of additional high bay manufacturing space.  The Company was responsible for a portion of the construction costs and was deemed to be the owner of the building during the construction period under FASB ASC 840, Leases.

In October 2014, the Company entered into an amendment of its lease agreement for the Billerica facilities extending the term of the lease through February 28, 2023 with an adjusted rent schedule commencing October 1, 2014. Due to certain provisions of the amended lease agreements which removed certain continuing financing obligations related to the building, it was determined that the lease no longer qualified as a capital lease and as such, the Company removed the capitalized building, associated accumulated depreciation and lease financing liability from its books.  The associated gain of $381,000 resulting from the removal of the building from our books was deferred and is being amortized over the modified lease term of the property.

XML

COMMITMENTS AND CONTINGENCIES

9 Months Ended

Dec. 31, 2015

COMMITMENTS AND CONTINGENCIES.

COMMITMENTS AND CONTINGENCIES

10.COMMITMENTS AND CONTINGENCIES

Deferred Revenue

The Company offers extended warranty and service contracts to its customers. These contracts typically cover a period of one to five years, and include advance payments that are recorded as deferred revenue. Revenue is recognized as services are performed over the life of the contract, which represents the period over which these revenues are earned. Costs associated with these extended warranty and service contracts are expensed to cost of sales and contracts as incurred.

Legal Matters

The Company continues to cooperate with the Office of the Inspector General (“OIG”) of the U.S. General Services Administration (“GSA”) with respect to a subpoena issued on April 17, 2015 and a related investigation being conducted in conjunction with the Department of Defense.  The investigation relates to the Company’s discount practices and compliance with the pricing provisions of the Company’s GSA Schedule contract.  AS&E produced responsive materials to the GSA OIG from May 2015 through November 2015.  The Company continues to cooperate fully with the investigation and at this time management is unable to predict the outcome of the investigation or estimate the amount of possible loss or range of loss with any certainty.  It is possible that the investigation could lead to claims or findings of violations of the False Claims Act in connection with the Company’s GSA contracting activity. Violations of the False Claims Act could result in the imposition of damages, including up to treble damages, plus civil penalties in some cases. The Company has incurred, and will continue to incur, legal costs in connection with the investigation, and could incur other costs, damages or penalties, depending on its outcome, which could be material.

XML

SUBSEQUENT EVENT

9 Months Ended

Dec. 31, 2015

SUBSEQUENT EVENT

SUBSEQUENT EVENT

11.SUBSEQUENT EVENT

On February 8, 2016, the Company commenced a cost reduction plan to reduce operating expenses.  In connection with this plan, the Company initiated a workforce reduction. The reduction in workforce affected workers across all business areas of the business.  Affected employees are entitled to receive certain severance and other benefits consistent with their position and tenure with the Company.  The majority of the workforce reduction is expected to be completed by March 31, 2016.  In connection with the reduction, the Company expect to record a charge of approximately $1.6 million to $1.8 million in the fourth quarter fiscal 2016.

XML

GENERAL (Policies)

9 Months Ended

Dec. 31, 2015

GENERAL

Nature of Operations and Basis of Presentation

The condensed consolidated financial statements include the accounts of American Science and Engineering, Inc. and its wholly owned subsidiaries (the “Company”). All significant intercompany transactions and balances have been eliminated.

The unaudited condensed consolidated financial statements have been prepared in accordance with the requirements of Form 10-Q and consequently do not include all disclosures required by Form 10-K. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2015, or fiscal 2015, as filed with the Securities and Exchange Commission on June 5, 2015.

The unaudited condensed consolidated financial statements, in the opinion of management, include all necessary adjustments, consisting solely of normal recurring adjustments, to present fairly the Company’s financial position, results of operations and cash flows.  These results are not necessarily indicative of the results to be expected for the entire year.

Nature of Operations

The Company develops, manufactures, markets, and sells X-ray inspection and other detection products for homeland security, force protection, public safety and other critical defense and security applications.  The Company provides maintenance, warranty, engineering, and training and operator services related to these products.  The Company has one reporting segment, X-ray detection solutions.

Revenue Recognition

Significant Accounting Policies

For systems that are produced in a standard manufacturing operation and have shorter order to delivery cycles, the Company recognizes sales when title passes and when other revenue recognition criteria (such as transfer of risk and customer acceptance) are met.  Revenues on cost reimbursable and custom long-term fixed price contracts are generally recorded as costs are incurred using the percentage of completion method.

The other significant accounting policies followed by the Company and its subsidiaries in preparing its consolidated financial statements are set forth in Note 1 to the consolidated financial statements included in its Form 10-K for the year ended March 31, 2015.  There have been no changes to the Company’s critical accounting policies during the three and nine months December 31, 2015.

Stock Repurchase Program and Dividends

Stock Repurchase Program

On May 7, 2013, the Board of Directors announced the approval of its fifth Stock Repurchase Program which authorized the Company to repurchase up to $35 million of shares of its common stock from time to time on the open market or in privately negotiated transactions.  On December 1, 2014, the Board of Directors announced an expansion of this stock repurchase program increasing the program authorization to $50 million of shares of its common stock.

During the nine months ended December 31, 2015, the Company repurchased 54,056 shares of its common stock at an average price of $41.86.  The Company did not repurchase any shares of stock in the three months ended December 31, 2015.  As of December 31, 2015, the remaining balance available under the Stock Repurchase Program was $11,225,000.

Dividends

	Three Months Ended				Nine Months Ended
(In thousands)	December 31, 2015		December 31, 2014		December 31, 2015		December 31, 2014
Dividends declared	$	0.50	$	0.50	$	1.50	$	1.50
Dividends paid	$	0.50	$	0.50	$	1.50	$	1.50

On February 8, 2016, the Company declared a cash dividend of $0.50 per share. The dividend will be paid on March 2, 2016 to all shareholders of record at the close of business on February 18, 2016.  Future dividends will be declared at the discretion of the Board of Directors and will depend upon such factors as the Board of Directors deems relevant.

Concentrations of Credit Risk

Concentrations of Credit Risk

Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of cash and cash equivalents, restricted cash, short-term investments and accounts and unbilled receivables.  At times, the Company maintains cash balances in excess of insured limits. The Company maintains its cash and cash equivalents with major financial institutions.  The Company’s credit risk is managed by investing its cash in money market funds, investment grade corporate debentures/bonds, U.S. government agency bonds, commercial paper, U.S. treasury bills and certificates of deposit.

New Accounting Pronouncements

New Accounting Pronouncements

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue From Contracts With Customers, which outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. The ASU is based on the principle that an entity should recognize revenue in an amount that reflects the consideration to which an entity expects to be entitled in exchange for the goods or services transferred to its customers. The ASU also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to fulfill a contract. Entities have the option of using either a full retrospective or a modified retrospective approach for the adoption of the new standard. The guidance is effective for annual periods beginning on or after December 15, 2017 (early adoption for annual periods beginning on or after December 15, 2016 is permitted). The Company is currently assessing the impact that this standard will have on its consolidated financial statements.

In January 2015 the FASB issued ASU No. 2015-01, Income Statement—Extraordinary and Unusual Items, which eliminates from U.S. GAAP the concept of extraordinary items.  Entities may apply the amendments prospectively or retrospectively to all prior periods presented in the financial statements. Early adoption is permitted.  ASU No. 2015-01 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015.  The adoption of this standard is not expected to have a material effect on the Company’s consolidated financial statements.

In July 2015, the FASB issued ASU No. 2015-11, Simplifying the Measurement of Inventory, which requires an entity to measure inventory at the lower of cost and net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Subsequent measurement is unchanged for inventory measured using last-in, first-out (“LIFO”) or the retail inventory method. It is effective for annual reporting periods beginning after December 15, 2016. The amendments should be applied prospectively with earlier application permitted as of the beginning of an interim or annual reporting period. The Company is currently assessing the impact that this standard will have on its consolidated financial statements.

In November 2015, the FASB issued ASU No. 2015-17, “Balance Sheet Classification of Deferred Taxes (Topic 740, which eliminates the current requirement for companies to present deferred tax liabilities and assets as current and non-current in a classified balance sheet. To simplify the presentation of deferred income taxes, ASU 2015-17 requires that deferred tax liabilities and assets be classified as non-current in a classified statement of financial position. ASU 2015-17 is effective for fiscal years beginning after December 15, 2016 (our fiscal year 2018), including interim periods within that reporting period.  Early adoption is permitted as of the beginning of an interim or annual period. We are currently in the process of evaluating the impact of ASU 2015-17 on our financial position and results of operations.

XML

GENERAL (Tables)

9 Months Ended

Dec. 31, 2015

GENERAL

Schedule of dividends

	Three Months Ended				Nine Months Ended
(In thousands)	December 31, 2015		December 31, 2014		December 31, 2015		December 31, 2014
Dividends declared	$	0.50	$	0.50	$	1.50	$	1.50
Dividends paid	$	0.50	$	0.50	$	1.50	$	1.50

XML

ACCOUNTING FOR STOCK-BASED COMPENSATION (Tables)

9 Months Ended

Dec. 31, 2015

ACCOUNTING FOR STOCK-BASED COMPENSATION

Summary of stock-based compensation costs in the statements of operations and comprehensive income (loss)

	Three Months Ended				Nine Months Ended
(In thousands)	December 31, 2015		December 31, 2014		December 31, 2015		December 31, 2014
Cost of sales and contracts	$	176	$	124	$	289	$	647
Selling, general and administrative	629		372		1,560		1,619
Total share-based compensation expense before tax	$	805	$	496	$	1,849	$	2,266

Summary of stock option activity

	Number of Shares		Weighted Average Exercise Price ($)		Weighted Average Contractual Life (years)	Aggregate Intrinsic Value
Options outstanding at March 31, 2015	191,834		$	66.03	2.88
Grants	—		—
Exercises	—		—			—
Cancellations	(51,901	)	$	59.34
Options outstanding at December 31, 2015	139,933		$	68.51	2.83
Options exercisable at December 31, 2015	139,933

Schedule of information related to stock options by exercise price range

Information related to the stock options outstanding as of December 31, 2015 is as follows:

Range of Exercise Prices	Number of Shares	Weighted- Average Remaining Contractual Life (years)	Weighted- Average Exercise Price ($)		Exercisable Number of Shares	Exercisable Weighted- Average Exercise Price ($)
$  60.66-$69.99	83,752	2.20	$	64.24	83,752	$	64.24
$  70.00-$75.82	56,181	3.77	74.87		56,181	74.87
$  60.66-$75.82	139,933	2.83	$	68.51	139,933	$	68.51

Summary of the status of the non-vested restricted stock and stock unit awards

	Number of Shares		Weighted Average Grant Date Fair Value ($)
Outstanding at March 31, 2015	91,837		$	62.99
Granted	120,439		43.74
Vested	(23,347	)	55.65
Forfeited	(7,838	)	63.65
Outstanding at December 31, 2015	181,091		$	51.11

XML

INVENTORIES (Tables)

9 Months Ended

Dec. 31, 2015

INVENTORIES

Schedule of components of inventories

(In thousands)	December 31, 2015		March 31, 2015
Raw materials, completed sub-assemblies, and spare parts	$	21,372	$	20,334
Work-in-process	14,788		17,853
Finished goods	3,401		2,796
Total	$	39,561	$	40,983

XML

INCOME PER COMMON AND COMMON EQUIVALENT SHARE (Tables)

9 Months Ended

Dec. 31, 2015

INCOME PER COMMON AND COMMON EQUIVALENT SHARE

Schedule of calculation of basic and diluted earnings per share

	Three Months Ended						Nine Months Ended
(In thousands except per share amounts)	December 31, 2015			December 31, 2014			December 31, 2015			December 31, 2014
Income (Loss) Per Share — Basic:
Net income (loss)	$	(464	)	$	2,554		$	(515	)	$	102
Less: Distributed and undistributed earnings (loss) to unvested restricted stock units	(1		)	(27		)	(11		)	(4		)
Distributed and undistributed earnings (loss) to common shareholders — basic	(465		)	2,527			(526		)	98
Weighted average number of common shares outstanding — basic	7,164			7,789			7,158			7,866
Net income (loss) per share — basic	$	(0.06	)	$	0.32		$	(0.07	)	$	0.01
Diluted:
Weighted average number of common shares outstanding	7,164			7,789			7,158			7,866
Add dilutive effect of potential common shares	—			7			—			11
Weighted average number of common and potential common shares outstanding — diluted	7,164			7,796			7,158			7,877
Net income (loss) per share — diluted	$	(0.06	)	$	0.32		$	(0.07	)	$	0.01

XML

FAIR VALUE MEASUREMENTS (Tables)

9 Months Ended

Dec. 31, 2015

FAIR VALUE MEASUREMENTS

Schedule of financial assets measured at fair value on recurring basis, based on the fair value hierarchy

(In thousands)	December 31, 2015		March 31, 2015
Level 1 — Financial Assets
Money market funds	$	63,485	$	51,784
Treasury bills	—		5,403
Total Level 1 Financial Assets	63,485		57,187
Level 2 — Financial Assets
Corporate debentures/bonds	3,000		13,813
Government agency bonds	—		5,317
Total Level 2 Financial Assets	3,000		19,130
Total cash equivalents and short-term investments	$	66,485	$	76,317

Schedule of available-for-sale securities

(In thousands)	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses		Fair Value
December 31, 2015:
Short-term investments:
Corporate debentures/bonds	$	3,000	$	—	$	—	$	3,000
Total short-term investments	$	3,000	$	—	$	—	$	3,000
Cash equivalents:
Money market funds	$	63,485	$	—	$	—	$	63,485
Total cash equivalents	$	63,485	$	—	$	—	$	63,485

(In thousands)	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
March 31, 2015:
Short-term investments:
Corporate debentures/bonds	$	13,823	$	—	$	(10	)	$	13,813
Government agency bonds	5,315		2		—			5,317
Treasury bills	5,400		3		—			5,403
Total short-term investments	$	24,538	$	5	$	(10	)	$	24,533
Cash equivalents:
Money market funds	$	51,784	$	—	$	—		$	51,784
Total cash equivalents	$	51,784	$	—	$	—		$	51,784

XML

GUARANTEES (Tables)

9 Months Ended

Dec. 31, 2015

GUARANTEES

Schedule of warranty experience

	Three Months Ended						Nine Months Ended
(In thousands)	December 31, 2015			December 31, 2014			December 31, 2015			December 31, 2014
Warranty accrual - beginning of period	$	200		$	186		$	159		$	404
Accruals for warranties issued during the period	107			99			281			184
Adjustment of preexisting accrual estimates	(62		)	(42		)	(26		)	(202		)
Warranty costs incurred during the period	(24		)	(61		)	(193		)	(204		)
Warranty accrual — end of period	$	221		$	182		$	221		$	182

XML

GENERAL - REPORTING SEGMENTS (Details)	9 Months Ended
	Dec. 31, 2015 segment
Nature of Operations
Number of reporting segments	1

XML

GENERAL - STOCK REPURCHASE PROGRAM (Details) - USD ($)			3 Months Ended		9 Months Ended
	Mar. 02, 2016	Feb. 08, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 01, 2014	May. 07, 2013
Dividends
Dividends declared (in dollars per share)		$ 0.50	$ 0.50	$ 0.50	$ 1.50	$ 1.50
Dividends paid (in dollars per share)			$ 0.50	$ 0.50	$ 1.50	$ 1.50
Forecast
Dividends
Dividends paid (in dollars per share)	$ 0.50
Stock Repurchase Program
Stock Repurchase Program
Number of shares repurchased under the stock repurchase program			0		54,056
Average price of shares repurchased					$ 41.86
Maximum dollar value of shares that may still be purchased under stock repurchase program			$ 11,225,000		$ 11,225,000
Fifth Stock Repurchase Program
Stock Repurchase Program
Authorized amount of repurchase of common stock							$ 50,000,000	$ 35,000,000

XML

ACCOUNTING FOR STOCK-BASED COMPENSATION - COST SUMMARY (Details) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2015	Dec. 31, 2014
Stock-based compensation cost
Share-based compensation expense before tax	$ 805,000	$ 496,000	$ 1,849,000	$ 2,266,000
Income tax benefit recognized related to the compensation costs	282,000	223,000	648,000	816,000
Cost of sales and contracts
Stock-based compensation cost
Share-based compensation expense before tax	176,000	124,000	289,000	647,000
Selling, general and administrative expenses
Stock-based compensation cost
Share-based compensation expense before tax	$ 629,000	$ 372,000	$ 1,560,000	$ 1,619,000

XML

ACCOUNTING FOR STOCK-BASED COMPENSATION - ACTIVITY (Details) - USD ($)	3 Months Ended	9 Months Ended	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2015	Mar. 31, 2015
Stock Option and Other Compensation Plans
Number of shares that remain available for future issuance under the plans	366,000	366,000
Minimum
Stock Option and Other Compensation Plans
Vesting period for awards granted under the plans		1 year
Maximum
Stock Option and Other Compensation Plans
Vesting period for awards granted under the plans		3 years
Stock options
Stock Option and Other Compensation Plans
Term of awards from the date of grant		10 years
Number of Shares
Options outstanding at the beginning of the period (in shares)		191,834
Grants (in shares)	0	0
Cancellations (in shares)		(51,901)
Options outstanding at the end of the period (in shares)	139,933	139,933	191,834
Options exercisable at the end of the period (in shares)	139,933	139,933
Weighted Average Exercise Price
Options outstanding at the beginning of the period (in dollars per share)		$ 66.03
Cancellations (in dollars per share)		59.34
Options outstanding at the end of the period (in dollars per share)	$ 68.51	$ 68.51	$ 66.03
Weighted Average Contractual Life
Options outstanding at the end of the period		2 years 9 months 29 days	2 years 10 months 17 days
Remaining unrecognized compensation cost (in dollars)	$ 0	$ 0

XML

ACCOUNTING FOR STOCK-BASED COMPENSATION - STOCK OPTIONS OUTSTANDING (Details) - Stock options	9 Months Ended
	Dec. 31, 2015 $ / shares shares
$60.66-$69.99
Information related to the stock options outstanding
Exercise price, low end of range (in dollars per share)	$ 60.66
Exercise price, high end of range (in dollars per share)	$ 69.99
Number of Shares | shares	83,752
Weighted-Average Remaining Contractual Life	2 years 2 months 12 days
Weighted-Average Exercise Price (in dollars per share)	$ 64.24
Exercisable Number of Shares | shares	83,752
Exercisable Weighted-Average Exercise Price (in dollars per share)	$ 64.24
$70.00-$75.82
Information related to the stock options outstanding
Exercise price, low end of range (in dollars per share)	70.00
Exercise price, high end of range (in dollars per share)	$ 75.82
Number of Shares | shares	56,181
Weighted-Average Remaining Contractual Life	3 years 9 months 7 days
Weighted-Average Exercise Price (in dollars per share)	$ 74.87
Exercisable Number of Shares | shares	56,181
Exercisable Weighted-Average Exercise Price (in dollars per share)	$ 74.87
$60.66-$75.82
Information related to the stock options outstanding
Exercise price, low end of range (in dollars per share)	60.66
Exercise price, high end of range (in dollars per share)	$ 75.82
Number of Shares | shares	139,933
Weighted-Average Remaining Contractual Life	2 years 9 months 29 days
Weighted-Average Exercise Price (in dollars per share)	$ 68.51
Exercisable Number of Shares | shares	139,933
Exercisable Weighted-Average Exercise Price (in dollars per share)	$ 68.51

XML

ACCOUNTING FOR STOCK-BASED COMPENSATION - NON-VESTED AND RESTERICTED STOCK UNITS (Details)	9 Months Ended
	Dec. 31, 2015 USD ($) $ / shares shares
Minimum
Stockholder's equity
Vesting period for awards granted under the plans	1 year
Maximum
Stockholder's equity
Vesting period for awards granted under the plans	3 years
Restricted Stock and Restricted Stock Units
Stockholder's equity
Unrecognized compensation costs (in dollars) | $	$ 5,546,000
Expected period to recognize unrecognized compensation costs	1 year 6 months 18 days
Number of Shares
Outstanding at the beginning of the period (in shares) | shares	91,837
Granted (in shares) | shares	120,439
Vested (in shares) | shares	(23,347)
Forfeited (in shares) | shares	(7,838)
Outstanding at the end of the period (in shares) | shares	181,091
Weighted Average Grant Date Fair Value
Outstanding at the beginning of the period (in dollars per share) | $ / shares	$ 62.99
Granted (in dollars per share) | $ / shares	43.74
Vested (in dollars per share) | $ / shares	55.65
Forfeited (in dollars per share) | $ / shares	63.65
Outstanding at the end of the period (in dollars per share) | $ / shares	$ 51.11
Restricted Stock and Restricted Stock Units | Employees | Minimum
Stockholder's equity
Vesting period for awards granted under the plans	1 year
Restricted Stock and Restricted Stock Units | Employees | Maximum
Stockholder's equity
Vesting period for awards granted under the plans	3 years
Restricted Stock | Non-employee directors
Stockholder's equity
Vesting period for awards granted under the plans	1 year

XML

INVENTORIES (Details) - USD ($) $ in Thousands	Dec. 31, 2015	Mar. 31, 2015
INVENTORIES
Raw materials, completed sub-assemblies, and spare parts	$ 21,372	$ 20,334
Work-in-process	14,788	17,853
Finished goods	3,401	2,796
Total	$ 39,561	$ 40,983

XML

INCOME PER COMMON AND COMMON EQUIVALENT SHARE (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2015	Dec. 31, 2014
INCOME PER COMMON AND COMMON EQUIVALENT SHARE
Common stock equivalents excluded from diluted earnings per share as their effect is anti-dilutive (in shares)	331,000	244,000	358,000	209,000
Income (Loss) Per Share - Basic:
Net income (loss)	$ (464)	$ 2,554	$ (515)	$ 102
Less: Distributed and undistributed earnings (loss) to unvested restricted stock units	(1)	(27)	(11)	(4)
Distributed and undistributed earnings (loss) to common shareholders	$ (465)	$ 2,527	$ (526)	$ 98
Weighted average number of common shares outstanding (in shares)	7,164,000	7,789,000	7,158,000	7,866,000
Net income (loss) per share - basic (in dollars per share)	$ (0.06)	$ 0.32	$ (0.07)	$ 0.01
Diluted:
Weighted average number of common shares outstanding (in shares)	7,164,000	7,789,000	7,158,000	7,866,000
Add dilutive effect of potential common shares (in shares)		7,000		11,000
Weighted average number of common and potential common shares outstanding - diluted (in shares)	7,164,000	7,796,000	7,158,000	7,877,000
Net income (loss) per share - diluted (in dollars per share)	$ (0.06)	$ 0.32	$ (0.07)	$ 0.01

XML

LETTERS OF CREDIT (Details) - USD ($)	Dec. 31, 2015	Mar. 31, 2015
Credit facilities
Long-term restricted cash, as determined by the expiration date of the underlying letters of credit	$ 1,587,000	$ 208,000
Standby letters of credit
Credit facilities
Outstanding Amount	13,409,000
Restricted cash balance	7,189,000
Long-term restricted cash, as determined by the expiration date of the underlying letters of credit	$ 1,587,000
Standby letters of credit | Minimum
Credit facilities
Percentage of outstanding amount that is cash secured	52.00%
Standby letters of credit | Maximum
Credit facilities
Percentage of outstanding amount that is cash secured	63.00%

XML

FAIR VALUE MEASUREMENTS - FINANCIAL ASSETS (Details) - Recurring basis - USD ($) $ in Thousands	Dec. 31, 2015	Mar. 31, 2015
Total fair value
Financial Assets
Total cash equivalents and short-term investments	$ 66,485	$ 76,317
Level 1
Financial Assets
Total cash equivalents and short-term investments	63,485	57,187
Level 1 | Treasury bills
Financial Assets
Total cash equivalents and short-term investments		5,403
Level 1 | Money market funds
Financial Assets
Total cash equivalents and short-term investments	63,485	51,784
Level 2
Financial Assets
Total cash equivalents and short-term investments	3,000	19,130
Level 2 | Corporate debentures/bonds
Financial Assets
Total cash equivalents and short-term investments	$ 3,000	13,813
Level 2 | Government agency bonds
Financial Assets
Total cash equivalents and short-term investments		$ 5,317

XML

FAIR VALUE MEASUREMENTS - AVAILABLE-FOR-SALE SECURITIES (Details) - USD ($) $ in Thousands	9 Months Ended
	Dec. 31, 2015	Mar. 31, 2015
Maximum
Available-for-sale securities
Contractual maturity period	7 months
Short-term investments.
Available-for-sale securities
Amortized Cost	$ 3,000	$ 24,538
Gross Unrealized Gains		5
Gross Unrealized Losses		(10)
Fair Value	3,000	24,533
Short-term investments. | Corporate debentures/bonds
Available-for-sale securities
Amortized Cost	3,000	13,823
Gross Unrealized Losses		(10)
Fair Value	3,000	13,813
Short-term investments. | Government agency bonds
Available-for-sale securities
Amortized Cost		5,315
Gross Unrealized Gains		2
Fair Value		5,317
Short-term investments. | Treasury bills
Available-for-sale securities
Amortized Cost		5,400
Gross Unrealized Gains		3
Fair Value		5,403
Cash equivalents
Available-for-sale securities
Amortized Cost	63,485	51,784
Fair Value	63,485	51,784
Cash equivalents | Money market funds
Available-for-sale securities
Amortized Cost	63,485	51,784
Fair Value	$ 63,485	$ 51,784

XML

INCOME TAXES (Details)	9 Months Ended
	Dec. 31, 2015
INCOME TAXES
Number of years of cumulative income based upon which valuation allowance is evaluated	3 years

XML

GUARANTEES (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2015	Dec. 31, 2014
GUARANTEES
Warranty period for certain products			1 year
Historical experience trailing period based on how product warranty accrual rates are determined			12 months
Warranty Experience
Warranty accrual at beginning of period	$ 200	$ 186	$ 159	$ 404
Accruals for warranties issued during the period	107	99	281	184
Adjustment of preexisting accrual estimates	(62)	(42)	(26)	(202)
Warranty costs incurred during period	(24)	(61)	(193)	(204)
Warranty accrual at end of period	$ 221	$ 182	$ 221	$ 182

XML

LEASE COMMITMENTS (Details)	Oct. 31, 2014 USD ($)
LEASE COMMITMENTS
Gain deferred from the removal of building	$ 381,000

XML

COMMITMENTS AND CONTINGENCIES (Details)	9 Months Ended
	Dec. 31, 2015
COMMITMENTS AND CONTINGENCIES.
Minimum period covered under extended warranty and service contracts	1 year
Maximum period covered under extended warranty and service contracts	5 years

XML

SUBSEQUENT EVENT (Details) - Subsequent Event. - Forecast $ in Millions	3 Months Ended
	Mar. 31, 2016 USD ($)
Minimum
Severance and other charges
Expected charge	$ 1.6
Maximum
Severance and other charges
Expected charge	$ 1.8